Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/22/17 | Current report filing |
|
3 | ||
| 12/19/17 | Current report filing |
|
29 | ||
| 12/12/17 | Current report filing |
|
5 | ||
| 11/29/17 | Current report filing |
|
6 | ||
| 11/15/17 | Current report filing |
|
42 | ||
| 11/14/17 | Quarterly report pursuant to Section 13 or 15(d) |
|
 |
60 | |
| 11/08/17 | Current report filing |
|
8 | ||
| 10/25/17 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 10/19/17 | Prospectus filed pursuant to Rule 424(b)(5) |
|
64 | ||
| 10/19/17 | Current report filing |
|
39 |